The global demand for Pharmaceutical Grade Phycocyanin Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Phycocyanin is a water soluble, nontoxic and natural molecule with anticancer, antioxidant, antiviral and anti-inflammatory activities. Major part of phycocyanin is used for pharmaceutical applications. It is a powerful agent for the immune system in human and animals and provides protection from a number of diseases. Phycocyanin is widely accepted as potent anticancer in various cell types like breast cancer, lung cancer, and bone marrow cancer. It has potentials in the area of immunomodulation, anticancer, antiviral, and cholesterol-reduction effects. It plays an important role in balancing immune cells and cytokines to prevent excess production that could lead to an impaired immune system.
Pharmaceutical grade phycocyanin is projected to grow at a significant rate during the forecast period. Rising global burden of cancer is estimated driving the demand for pharmaceutical grade phycocyanin. Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Cancer is the subsequent driving reason for death all around and is liable for an expected 9.6 million deaths in 2018. All-inclusive, around 1 of every 6 deaths is because of cancer. Phycocyanin is used in medicine to facilitate selective destruction of atherosclerotic plaques or cancer cells by radiation with little or no damage to the surrounding cells or tissue. Exploring pharmaceutical potentials will boost the demand for pharmaceutical grade phycocyanin. Clinical significance of phycocyanin has been recorded in heart, kidney, lungs, cancer, neurological disease, antiinflammation, cataract, and liver diseases.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of pharmaceutical grade phycocyanin.
The entire pharmaceutical grade phycocyanin market has been sub-categorized into application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
This section covers regional segmentation which accentuates on current and future demand for pharmaceutical grade phycocyanin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Pharmaceutical Grade Phycocyanin Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pharmaceutical grade phycocyanin market include DIC Corporation, Zeoes Biotech, Japan Algae, Parry Nutraceuticals, Ozone Naturals. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.